Aljian Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,488
Closed -$429K 44
2023
Q2
$429K Sell
1,488
-93
-6% -$28.2K 0.19% 34
2023
Q1
$504K Buy
1,581
+69
+5% +$20.5K 0.25% 29
2022
Q4
$445K Buy
1,512
+126
+9% +$34.8K 0.26% 34
2022
Q3
$320K Sell
1,386
-33
-2% -$8.27K 0.18% 39
2022
Q2
$306K Sell
1,419
-98
-6% -$22.3K 0.17% 44
2022
Q1
$411K Buy
1,517
+33
+2% +$8.1K 0.17% 42
2021
Q4
$395K Buy
1,484
+18
+1% +$5.22K 0.15% 48
2021
Q3
$418K Buy
1,466
+42
+3% +$12K 0.18% 44
2021
Q2
$391K Buy
1,424
+102
+8% +$27.7K 0.17% 45
2021
Q1
$346K Buy
1,322
+113
+9% +$30.3K 0.17% 48
2020
Q4
$309K Buy
1,209
+103
+9% +$25.6K 0.16% 43
2020
Q3
$262K Sell
1,106
-60
-5% -$12.6K 0.15% 43
2020
Q2
$227K Buy
+1,166
New +$223K 0.15% 39

Other funds holding PODD

Aljian Capital Management's PODD Position: Q3 2023 in Review

Aljian Capital Management sold out of Insulet (PODD) in Q3 2023, closing a stake of 1,488 shares — an estimated $429K sold.

Aljian Capital Management first reported a position in PODD in Q2 2020 and held it in 13 quarters. The position peaked at $504K in Q1 2023. 528 funds tracked by Wall St. Rank hold PODD as of Q3 2023.

  • Aljian Capital Management reported no remaining Insulet position as of Q3 2023 after selling out during the quarter.
  • Aljian Capital Management sold 1,488 Insulet shares in Q3 2023, an estimated $429K.
  • Aljian Capital Management first reported a position in Insulet in Q2 2020 and held it in 13 quarters.
  • Aljian Capital Management's Insulet position peaked at $504K in Q1 2023.
  • 528 funds tracked by Wall St. Rank held Insulet as of Q3 2023.

Based on Aljian Capital Management's 13F filing for Q3 2023, filed 26 Oct 2023.